Product NDC: | 55154-9386 |
Proprietary Name: | Piperacillin and Tazobactam |
Non Proprietary Name: | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM |
Active Ingredient(s): | 3; .375 g/15mL; g/15mL & nbsp; PIPERACILLIN SODIUM,TAZOBACTAM SODIUM |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-9386 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065523 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110531 |
Package NDC: | 55154-9386-5 |
Package Description: | 5 VIAL in 1 BAG (55154-9386-5) > 15 mL in 1 VIAL |
NDC Code | 55154-9386-5 |
Proprietary Name | Piperacillin and Tazobactam |
Package Description | 5 VIAL in 1 BAG (55154-9386-5) > 15 mL in 1 VIAL |
Product NDC | 55154-9386 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110531 |
Marketing Category Name | ANDA |
Labeler Name | Cardinal Health |
Substance Name | PIPERACILLIN; TAZOBACTAM |
Strength Number | 3; .375 |
Strength Unit | g/15mL; g/15mL |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |